Switching from Lexapro (Escitalopram) to Citalopram
You should not switch from escitalopram to citalopram quickly—this switch is clinically inadvisable and potentially harmful. Both medications carry the highest QT prolongation risk among SSRIs, and switching between them offers no therapeutic advantage while maintaining cardiac risk 1, 2.
Why This Switch Is Problematic
Cardiac Safety Concerns
Both escitalopram and citalopram are classified as having the highest risk for QT prolongation among SSRIs, with documented cases of Torsade de Pointes, ventricular tachycardia, and sudden death 1, 3. The 2023 Canadian Cardiovascular Society guidelines explicitly state that "risk among selective serotonin reuptake inhibitor antidepressants is highest with citalopram and escitalopram" 1. Both FDA and EMA have imposed maximum dose restrictions specifically for these two medications due to cardiac risks 2.
Lack of Therapeutic Rationale
- Escitalopram is the S-enantiomer of citalopram—they are essentially the same drug pharmacologically
- Citalopram requires twice the dose of escitalopram for equivalent effect (20mg citalopram ≈ 10mg escitalopram)
- Both have similar side effect profiles and discontinuation syndrome risks 3
- Switching provides no advantage in efficacy, tolerability, or safety
If You Must Switch (Direct Cross-Taper Method)
Only proceed if there is a compelling reason (e.g., insurance formulary requirements, cost considerations):
Step-by-Step Protocol
Calculate equivalent dose: Multiply current escitalopram dose by 2
- Escitalopram 10mg → Citalopram 20mg
- Escitalopram 20mg → Citalopram 40mg (maximum allowed dose) 4
Direct switch approach (same day):
Monitor for 2-4 weeks:
- Discontinuation symptoms (dizziness, paresthesias, anxiety, irritability) 3
- Cardiac symptoms if risk factors present
- Depression symptom stability
Critical Warnings
Dose limitations for citalopram 4:
- Maximum 40mg/day for adults under 60 years
- Maximum 20mg/day for patients >60 years, hepatic impairment, or CYP2C19 poor metabolizers
- Never exceed 40mg/day due to dose-dependent QT prolongation risk
Obtain baseline ECG if 1:
- Age >60 years or female sex (higher risk)
- Concurrent QT-prolonging medications
- Electrolyte disturbances or diuretic use
- Structural heart disease
- Baseline QTc >450ms (men) or >470ms (women)
Better Alternative Strategies
Instead of switching to citalopram, consider 1, 6:
Lower-Risk SSRIs
- Sertraline: Negligible QT risk, well-studied safety profile 1, 6
- Paroxetine: Negligible QT risk (though higher discontinuation syndrome risk) 1, 3
Direct Switch Protocol to Safer SSRI
For switching to sertraline (recommended):
- Stop escitalopram
- Start sertraline 50mg next day
- Titrate to 100-200mg over 1-2 weeks as tolerated 3
- Monitor for discontinuation symptoms during first week
Common Pitfalls to Avoid
- Don't assume generic citalopram is "safer": The cardiac risks are identical to brand-name 2
- Don't combine with other QT-prolonging drugs: Especially antipsychotics, macrolide antibiotics, or antiarrhythmics 1, 3
- Don't ignore age-related dose restrictions: Patients >60 require lower maximum doses 2, 4
- Don't switch for cost savings alone: Economic analyses show switching may increase total healthcare costs due to hospitalizations 7
Drug Interaction Caution
Both medications interact with other QT-prolonging drugs 3. Check www.crediblemeds.org before adding any new medication 1.